Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 104 Stomach Neoplasms 19 Inflammatory Breast Neoplasms 12 Esophageal Neoplasms 11 Triple Negative Breast Neoplasms 6 Sarcoma 6 Carcinoma, Hepatocellular 5 Lymphoma, Large B-Cell, Diffuse 4 Liver Neoplasms 4 Adenocarcinoma Of Esophagus 4 Primary Breast Cancer 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Hemangiosarcoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Testicular Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasm Metastasis 2 Malignant mesenchymal tumor 2 Lymphoma, B-Cell, Marginal Zone 2 Liposarcoma 2 Hemangiopericytoma, Malignant 2 Gallbladder Neoplasms 2 Fibrosarcoma 2 Desmoplastic Small Round Cell Tumor 2 Chondrosarcoma 2 Carcinoma, Ductal, Breast 2 Breast Neoplasms, Male 2

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoadjuvant Operable Breast Cancer × Epirubicin × Clear all

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡